Cystadenocarcinoma, Serous  >>  paclitaxel  >>  Phase 3
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
paclitaxel / Generic mfg.
SWOG-G0164, NCT00002819: Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer

Terminated
3
US
carboplatin, cyclophosphamide, mitoxantrone hydrochloride, paclitaxel, autologous bone marrow transplantation, peripheral blood stem cell transplantation
Gynecologic Oncology Group, National Cancer Institute (NCI), Eastern Cooperative Oncology Group, Southwest Oncology Group, Cancer and Leukemia Group B
Ovarian Cancer
02/00
 
NCT00002568: Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer

Completed
3
470
US
cisplatin, paclitaxel, conventional surgery
Gynecologic Oncology Group, National Cancer Institute (NCI)
Ovarian Cancer
12/04
 
NCT00003322: Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer

Completed
3
384
US, Canada
cisplatin, paclitaxel, quality-of-life assessment
Gynecologic Oncology Group, National Cancer Institute (NCI)
Ovarian Cancer, Primary Peritoneal Cavity Cancer
01/06
 
NCT00002717: Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Completed
3
324
US
cisplatin, paclitaxel
Gynecologic Oncology Group, National Cancer Institute (NCI)
Ovarian Cancer, Primary Peritoneal Cavity Cancer
10/07
 
NCT00006011: Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Completed
3
659
US
Doxorubicin Hydrochloride, Cisplatin, Filgrastim, G-CSF, Nivestim, r-metHuG-CSF, Pegfilgrastim, Filgrastim SD-01, GCSF-SD01, Neulasta, Paclitaxel, Anzatax, TAX
Gynecologic Oncology Group, Eastern Cooperative Oncology Group, National Cancer Institute (NCI)
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Endometrial Serous Adenocarcinoma, Stage III Uterine Corpus Cancer
03/10
 
ICON-7, NCT00483782 / 2005-003929-22: Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark ECCO-ESMO-ESTRO 2013
Sep 2013 - Sep 2013: ECCO-ESMO-ESTRO 2013
Checkmark P3 data for ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cavity cancer
More
Completed
3
1520
Europe, RoW
bevacizumab, carboplatin, paclitaxel, questionnaire administration, study of socioeconomic and demographic variables, quality-of-life assessment
Medical Research Council
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
 
 
NCT00003880: Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer

Terminated
2/3
132
US
recombinant adenovirus-p53 SCH-58500, carboplatin, paclitaxel
Merck Sharp & Dohme LLC
Ovarian Cancer, Primary Peritoneal Cavity Cancer
08/01
08/01

Download Options